Clinical Trials Browser

alovudine × Breast × Clear all

NCT01251874 2025-11-21

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02608216 2025-09-03

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms

NCT01928186 2018-05-15

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Phase NA Completed

28 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01222416 2017-07-02

PET/CT Evaluation of Treatment Response in Breast Cancer

Phase NA Terminated

50 enrolled 6 charts

Breast Neoplasms

NCT00572728 2016-12-30

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

Phase 2 Completed

90 enrolled 17 charts

Breast Neoplasms

NCT01480583 2016-07-13

GRABM-B

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms

NCT01018251 2015-12-15

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Phase NA Withdrawn

Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

NCT00534274 2014-12-16

Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy

Phase NA Completed

Breast Neoplasms

NCT01713049 2012-10-24

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

Phase NA Unknown

Breast Neoplasms